Despite making up half of the 64 million people living with heart failure, patients with this common form have no access to ...

NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

An earlier blood transfusion—done when hemoglobin levels were higher—after major general or vascular surgery among people ...

A polypill containing three recommended heart failure therapies improved heart function, reduced hospitalizations and was ...

A once-daily polypill containing 3 guideline-directed therapies for heart failure with reduced ejection fraction (HFrEF) led ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...

Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a “polypill” combination of three medications typically prescribed for heart failure, once daily for six months, ...

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced the publication in peer-reviewed journal Nature Medicine of 12-month ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

According to the American College of Cardiology, nearly 6.7 million Americans have heart failure, more than half with preserved ejection fraction. This condition often leads to frequent ...

The organisations will combine expertise with analytical technologies. The National Heart Centre Singapore and Agilent ...

Dr Yaranov highlights that heart failure can start quietly. He shares 7 early signs, and stresses the importance of ...